CTAP (TFA)

• Description :

  CTAP TFA is a potent, highly selective, and brain penetrant antagonist of μ-opioid receptor with IC50 of 3.5 nM. It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  ——

• Molecular Formula :

  ——

• Notes :

  Research use only, not for human use.

• Receptor :

  Δ-opioid receptor